Literature DB >> 3151097

Role of a mouse monoclonal IgE antibody in passive transfer of immunity to Schistosoma japonicum infection.

S Kojima1, T Janecharut, H Hata, M Niimura.   

Abstract

We have been able to produce a mouse monoclonal IgE antibody specific to an adult worm antigen extracted from Schistosoma japonicum (Sj). The antibody was able to elicit passive cutaneous anaphylaxis in the rat skin against Sj with the highest titer of 1:256,000 but did not cross-react with S. mansoni antigen. The antibody recognized a 97-kDa molecule expressed on the surface of mechanically transformed schistosoma of S. japonicum. Passive transfer of the antibody into mice in the early stage of challenge infection resulted in a partial but significant reduction of recovery of adult worms. Induction of eosinophilia by an oral administration of embryonated eggs of Toxocara canis prior to challenge infection enhanced the reduction.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3151097     DOI: 10.1590/s0074-02761987000800045

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  3 in total

1.  Vaccination with recombinant paramyosin in Montanide ISA206 protects against Schistosoma japonicum infection in water buffalo.

Authors:  Hannah Wei Wu; Zhi-Qiang Fu; Ke Lu; Sunthorn Pond-Tor; Rui Meng; Yang Hong; Kai Chu; Hao Li; Mario Jiz; Jin-Ming Liu; Ming Hou; Sangshin Park; Jiao-Jiao Lin; Jonathan D Kurtis
Journal:  Vaccine       Date:  2017-05-11       Impact factor: 3.641

Review 2.  Reassessing therapeutic antibodies for neglected and tropical diseases.

Authors:  Rob Hooft van Huijsduijnen; Somei Kojima; Dee Carter; Hisafumi Okabe; Akihide Sato; Wataru Akahata; Timothy N C Wells; Kei Katsuno
Journal:  PLoS Negl Trop Dis       Date:  2020-01-30

Review 3.  Development of Paramyosin as a Vaccine Candidate for Schistosomiasis.

Authors:  Mario A Jiz; Haiwei Wu; Remigio Olveda; Blanca Jarilla; Jonathan D Kurtis
Journal:  Front Immunol       Date:  2015-07-21       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.